1. Personalized cancer vaccine platform for clinically relevant oncolytic enveloped viruses;Ylösmäki;Mol. Ther.,2018
2. In cancer immunotherapy;Escors;N. J. Sci.,2014
3. Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy;Yang;Nat. Commun.,2021
4. Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models, Cancer Immunology;Zhang;Immunotherapy,2020
5. Failure of cancer vaccines: the significant limitations of this approach to immunotherapy;Bodey;Anticancer Res.,2000